PES After Soft Tissue Augmentation Using CTG Around Immediate Dental Implants Versus Immediate Dental Implants Alone in Esthetic Zone
Launched by NADA FAROUK HASAN ABD EL-AZIZ · Feb 1, 2018
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Implant became a treatment modality for replacing missing or non-restorable teeth, providing clinical success rate and esthetic outcome. (1) In esthetic zone the main goal is not only the preservation of function but also the preservation of the esthetics. The esthetic outcome of implant supported restoration depend on the soft tissue volume and the soft tissue contour. (2) The placement of immediate implant after tooth extraction was proved as a very high success rate treatment modality. It provided several advantages such as reduction of the time between tooth extraction and the placement...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Non-restorable teeth located within the maxillary anterior area and premolars. Age ranged between 20 to 50 years old. Sufficient vertical inter-arch space upon centric occlusion. Patients with good oral hygiene. Intact labial/buccal bone plate.
- • 10. a. Inclusion criteria
- • 1. Age: 20-50. 2. Patients with single non-restorable teeth in anterior or premolar area. 3. "Patients with adequate bone volume for the dental implant procedure". 5. Patients who are compliant to oral hygiene measures. 6. Patient consent approval and signing.
- 10. b. Exclusion criteria:
- • 1. Patients with any systemic disease that could affect normal healing of tissue and predictable outcome.
- • 2. Patients with any habits that might affect osseointegration, such as heavy smoking and alcoholism.
- • 3. Pregnant women.
- • 4. Patients with untreated periodontal disease or the presence of pathologic condition at implant site.
- • 5. Patients with Parafunctional habits that produce overload on the implant such as bruxism and clenching.
- • 6. Shallow palate.
About Nada Farouk Hasan Abd El Aziz
Nada Farouk Hasan Abd El-Aziz is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With expertise in clinical trial design and management, she focuses on innovative therapies and methodologies that address unmet medical needs. Her collaborative approach fosters partnerships with healthcare professionals and research institutions, ensuring rigorous adherence to regulatory standards and ethical guidelines. Through her leadership, she aims to contribute significantly to the field of clinical research, enhancing the understanding and treatment of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minya, Minia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials